Amgen reports higher profit and raises guidance
Amgen posted stronger-than-expected third-quarter earnings and raised its full-year outlook. Strong sales of newer drugs offset declines in older treatments.
Xurve View
Insights:
Xurve View

AMGEN INC reported third-quarter revenue rose 8% to $10.4B on Tuesday afternoon, outperforming Wall Street expectations.











